2013 ACR/ARHP Annual Meeting

October 25-30, 2013. San Diego, CA.

View by Title View Sessions

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Abstract Number: 2102

The Effect Of a Novel System Of Insoles Using Styrene Foam Beads On Foot Deformities In RA Patients
Abstract Number: 1978

The Effect Of Certolizumab On Lymphatic Volume and Flow In Rheumatoid Arthritis Patients With Acute Flare
Abstract Number: 1956

The Effect Of Initial Methotrexate Therapy On Cartilage Composition In Early Rheumatoid Arthritis: Follow-Up With Biochemical MRI Of Finger Cartilage
Abstract Number: 1759

The Effect Of Knee Replacement On Self-Reported Participation and Gait Speed: The Multicenter Osteoarthritis Study and The Osteoarthritis Initiative
Abstract Number: 2832

The Effect Of Maternal Antimalarial Intake During Pregnancy On The Risk Of Neonatal Lupus
Abstract Number: 488

The Effect Of Methotrexate On Adalimumab Pharmacokinetics: Pooled Analysis Of Adalimumab Pharmacokinetics In Patients With Rheumatoid Arthritis After Subcutaneous Administration
Abstract Number: 902

The Effect Of Obesity On Physical Function: The Osteoarthritis Initiative Study
Abstract Number: 1252

The Effect of Pretreatment With Resiniferatoxin On Dynamic Weight Bearing Measures and Evoked Pain Responses in An Acute Arthritis Murine Model
Abstract Number: 584

The Effect Of Ramipril On Endothelial Function and Endothelial Progenitor Cells In Patients With Systemic Lupus Erythematosus
Abstract Number: 2787

The Effect Of Smoking On The Clinical Expression Of ANCA-Associated Vasculitis
Abstract Number: 2117

The Effect Of Statin Therapy On Venous Thromboembolism After Hip Or Knee Arthroplasty
Abstract Number: 1181

The Effect Of Uric Acid Lowering Therapy In Preventing Comorbidity and Acute Attack Of Gout; A Retrospective Study
Abstract Number: 1368

The Effect Of Vitamin D On Early Rheumatoid Arthritis: A Retrospective Cohort Analysis
Abstract Number: 2370

The Effectiveness Of Biological Agents Concomitant With Tacrolimus In Rheumatoid Arthritis
Abstract Number: 1081

The Effects of Coexisting Cervical Myofascial Pain Syndromes On Pain and Disability of the Computer Users With Cumulative Trauma Disorders

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].